Takeda Pharmaceutical Co Ltd
DUS:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
DUS:TKD
|
JP |
|
Akzo Nobel NV
F:AKUP
|
NL |
|
Galderma Group AG
F:PY30
|
CH |
|
A
|
Atoss Software AG
XMUN:AOF
|
DE |
|
Promotora y Operadora de Infraestructura SAB de CV
F:AKY
|
MX |
|
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM
|
US |
|
V
|
Vale SA
F:CVLC
|
BR |
|
A
|
Avient Corp
XMUN:PY9
|
US |
|
Liontrust Asset Management PLC
LSE:LIO
|
UK |
|
T
|
TC Energy Corp
XMUN:TRS
|
CA |
|
T
|
Taylor Morrison Home Corp
F:THM
|
US |
|
D
|
Danaher Corp
XMUN:DAP
|
US |
|
T
|
Talanx AG
XMUN:TLX
|
DE |
|
F
|
Fanuc Corp
XMUN:FUC
|
JP |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 29.18 EUR with a low forecast of 24.26 EUR and a high forecast of 38.32 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
29.18
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 29.18 EUR with a low forecast of 24.26 EUR and a high forecast of 38.32 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 4 years is 2%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 3 years is 1%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-5%
Over the last 13 years, the compound annual growth rate for Operating Income has been 6%. The projected CAGR for the next 2 years is -5%.
What is the Pre-Tax Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
34%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -3%. The projected CAGR for the next 3 years is 34%.
What is the Net Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
43%
Over the last 13 years, the compound annual growth rate for Net Income has been -1%. The projected CAGR for the next 3 years is 43%.
